BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 28483909)

  • 1. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome.
    Wheaton K; Campuzano D; Ma W; Sheinis M; Ho B; Brown GW; Benchimol S
    Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence.
    Benson EK; Lee SW; Aaronson SA
    J Cell Sci; 2010 Aug; 123(Pt 15):2605-12. PubMed ID: 20605919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53.
    Kudlow BA; Stanfel MN; Burtner CR; Johnston ED; Kennedy BK
    Mol Biol Cell; 2008 Dec; 19(12):5238-48. PubMed ID: 18843043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
    Finley J
    Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
    Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
    J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
    Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
    Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria.
    Chojnowski A; Ong PF; Wong ES; Lim JS; Mutalif RA; Navasankari R; Dutta B; Yang H; Liow YY; Sze SK; Boudier T; Wright GD; Colman A; Burke B; Stewart CL; Dreesen O
    Elife; 2015 Aug; 4():. PubMed ID: 26312502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts.
    Cao K; Blair CD; Faddah DA; Kieckhaefer JE; Olive M; Erdos MR; Nabel EG; Collins FS
    J Clin Invest; 2011 Jul; 121(7):2833-44. PubMed ID: 21670498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progerin sequestration of PCNA promotes replication fork collapse and mislocalization of XPA in laminopathy-related progeroid syndromes.
    Hilton BA; Liu J; Cartwright BM; Liu Y; Breitman M; Wang Y; Jones R; Tang H; Rusinol A; Musich PR; Zou Y
    FASEB J; 2017 Sep; 31(9):3882-3893. PubMed ID: 28515154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.
    Gonzalo S; Kreienkamp R; Askjaer P
    Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 isoforms regulate premature aging in human cells.
    von Muhlinen N; Horikawa I; Alam F; Isogaya K; Lissa D; Vojtesek B; Lane DP; Harris CC
    Oncogene; 2018 May; 37(18):2379-2393. PubMed ID: 29429991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
    Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
    Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient introduction of human telomerase mRNA improves hallmarks of progeria cells.
    Li Y; Zhou G; Bruno IG; Zhang N; Sho S; Tedone E; Lai TP; Cooke JP; Shay JW
    Aging Cell; 2019 Aug; 18(4):e12979. PubMed ID: 31152494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterochromatin loss as a determinant of progerin-induced DNA damage in Hutchinson-Gilford Progeria.
    Chojnowski A; Ong PF; Foo MXR; Liebl D; Hor LP; Stewart CL; Dreesen O
    Aging Cell; 2020 Mar; 19(3):e13108. PubMed ID: 32087607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hutchinson-Gilford progeria syndrome through the lens of transcription.
    Prokocimer M; Barkan R; Gruenbaum Y
    Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
    Glynn MW; Glover TW
    Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts.
    Eisch V; Lu X; Gabriel D; Djabali K
    Oncotarget; 2016 Apr; 7(17):24700-18. PubMed ID: 27015553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
    Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
    Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
    Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson-Gilford Progeria Syndrome.
    Aguado J; Sola-Carvajal A; Cancila V; Revêchon G; Ong PF; Jones-Weinert CW; Wallén Arzt E; Lattanzi G; Dreesen O; Tripodo C; Rossiello F; Eriksson M; d'Adda di Fagagna F
    Nat Commun; 2019 Nov; 10(1):4990. PubMed ID: 31740672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.